Search

Richard T Beresis

from San Francisco, CA
Age ~58
Get Report
Also known as:
Dick T Beresis, Rick T Beresis, Richard T Jacobson
Related to:
Lawrence WeissmanMicael Beresis, 53Dorothy BeresisHenry Beresis, 89Michael Beresis, 53
Connected to:
Stephen W Beresk, 75Charles L Beresky, 51Paul M Beresniewicz, 44Robert M Berest, 80Terry L Bereta, 29Eric D Berets, 58Robert A Beretski, 74Alda M Beretta, 39Dante G Beretta, 65Donna E Beretta, 71

Richard Beresis Phones & Addresses

  • San Francisco, CA
  • Effort, PA
  • Rahway, NJ
  • 23 Village Dr, Matawan, NJ 07747 (732) 583-6369
  • 113 Sullivan St, New York, NY 10012 (212) 219-2214
  • Boston, MA
  • Brooklyn, NY
  • San Diego, CA
  • Brookline, MA

Work

Company: Shanghai chempartner Oct 2009 Position: Senior director, discovery chemistry

Education

School / High School: Boston University 1990 to 1996 Specialities: Organic Chemistry

Skills

Medicinal Chemistry • Drug Discovery • Chemistry • Drug Design • Organic Chemistry • Gpcrs • Pharmaceutical Industry • Biotechnology • Cro • Kinases • Protein Chemistry • Organic Synthesis • Project Management • Nuclear Hormone Receptors • Fabf Inhibitors • Autoimmune Diseases • Asthma • Rheumatoid Arthritis • Anti Microbials • Anti Inflammatory • Tuberculosis • Pro Drugs • Chronic Pain • Atherosclerosis • Oncology • Combinatorial Chemistry • Patents • Business Development • Project Coordination • Contract Research Organization • Cross Functional Team Leadership • Molecular Modeling • International Project Management • Natural Products • Outsourcing • Outsourcing Management • Hiv • Asymmetric Synthesis • Leadership • Synthetic Organic Chemistry • Cardiovascular Disease • Lifesciences • Heterocyclic Chemistry • R&D • Immunology • Parallel Synthesis • Cns Disorders • Cancer Immunotherapy • China Business Development • Neuroscience

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Richard Beresis Photo 1

Senior Director, Discovery Chemistry

View page
Location:
1800 Bryant St, San Francisco, CA 94110
Industry:
Pharmaceuticals
Work:
Shanghai Chempartner
Senior Director, Discovery Chemistry
The Chemistry Research Solution Oct 2008 - Sep 2009
Vice President of Business Development
Beresis Consulting Aug 2007 - Jun 2009
Principle Pharmaceutical Consultant
Merck Sep 1998 - Oct 2006
Senior Research Fellow, Medicinal Chemistry
The Scripps Research Institute Aug 1996 - Aug 1998
Nih Post-Doctoral Research Fellow
Education:
Boston University 1990 - 1996
Rutgers University 1984 - 1989
Skills:
Medicinal Chemistry
Drug Discovery
Chemistry
Drug Design
Organic Chemistry
Gpcrs
Pharmaceutical Industry
Biotechnology
Cro
Kinases
Protein Chemistry
Organic Synthesis
Project Management
Nuclear Hormone Receptors
Fabf Inhibitors
Autoimmune Diseases
Asthma
Rheumatoid Arthritis
Anti Microbials
Anti Inflammatory
Tuberculosis
Pro Drugs
Chronic Pain
Atherosclerosis
Oncology
Combinatorial Chemistry
Patents
Business Development
Project Coordination
Contract Research Organization
Cross Functional Team Leadership
Molecular Modeling
International Project Management
Natural Products
Outsourcing
Outsourcing Management
Hiv
Asymmetric Synthesis
Leadership
Synthetic Organic Chemistry
Cardiovascular Disease
Lifesciences
Heterocyclic Chemistry
R&D
Immunology
Parallel Synthesis
Cns Disorders
Cancer Immunotherapy
China Business Development
Neuroscience
Languages:
English

Publications

Us Patents

(Pyrimidinyl) (Phenyl) Substituted Fused Heteroaryl P38 Inhibiting And Pkg Kinase Inhibiting Compounds

View page
US Patent:
7196095, Mar 27, 2007
Filed:
Jun 21, 2002
Appl. No.:
10/477367
Inventors:
Tesfaye Biftu - Westfield NJ, US
Richard Beresis - Matawan NJ, US
Richard Berger - Cranford NJ, US
Steven L. Colletti - Princeton Junction NJ, US
James B. Doherty - Montvale NJ, US
Dennis D. Feng - Branchburg Township NJ, US
Dennis M. Schmatz - Cranford NJ, US
Xiaoxia Qian - New York NY, US
David A. Claremon - Maple Glen PA, US
Nigel J. Liverton - Harleysville PA, US
Charles J. McIntyre - Lansdale PA, US
Ernest W. Kovacs - Weehawken NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 403/04
C07D 403/14
C07D 417/04
C07D 417/14
A61K 31/506
A61P 19/02
US Classification:
514275, 514243, 5142591, 544331, 544184, 544281
Abstract:
Compounds of formula (I) and pharmaceutically acceptable salts thereof are useful in the treatment of cytokine mediated diseases such as arthritis and in the treatment and/or prevention of protozoal diseases such as coccidiosis.

Selective Non-Steroidal Glucocorticoid Receptor Modulators

View page
US Patent:
7411073, Aug 12, 2008
Filed:
Feb 20, 2004
Appl. No.:
10/544899
Inventors:
Amjad Ali - Piscataway NJ, US
Richard Beresis - Matawan NJ, US
Steven L. Colletti - Princeton Junction NJ, US
Donald W. Graham - Mountainside NJ, US
James R. Tata - Westfield NJ, US
Christopher F. Thompson - Clark NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 231/54
A01N 43/56
US Classification:
5483591, 514406
Abstract:
The present invention encompasses compounds of Formula (I) or pharmaceutically acceptable salts or hydrates thereof, which are useful as novel non-steroidal selective glucocorticoid receptor modulators for treating a variety of autoimmune and inflammatory diseases or conditions, and possess advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity and/or metabolism. Pharmaceutical compositions and methods of use are also included.

Selective Spirocyclic Glucocorticoid Receptor Modulators

View page
US Patent:
7662846, Feb 16, 2010
Filed:
Apr 19, 2004
Appl. No.:
10/551933
Inventors:
Amjad Ali - Piscataway NJ, US
James M. Balkovec - Martinsville NJ, US
Richard Beresis - Matawan NJ, US
Steven L. Colletti - Princeton Junction NJ, US
Donald W. Graham - Mountainside NJ, US
Gool F. Patel - Califon NJ, US
Cameron J. Smith - Lawrenceville NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/00
A01N 43/56
US Classification:
514403, 5483591
Abstract:
The present invention encompasses compounds of Formula (I) and Formula (II) or pharmaceutically acceptable salts or hydrates thereof, which are useful as selective glucocorticoid receptor ligands for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included.

Phenyl Substituted Imidaopyridines And Phenyl Substituted Benzimidazoles

View page
US Patent:
20050165232, Jul 28, 2005
Filed:
May 9, 2003
Appl. No.:
10/513932
Inventors:
Richard Beresis - Matawan NJ, US
Steven Colletti - Princeton Junction NJ, US
James Doherty - Montvale NJ, US
Dennis Zaller - Scotch Plains NJ, US
International Classification:
C07D043/02
A61K031/501
US Classification:
544238000, 514252060
Abstract:
Compounds described by the formula (I) or formula (II): (I), (II), or pharmaceutically acceptable salts thereof, are inhibitors of p38 useful in the treatment of inflammatory diseases such as arthritis. Compounds may be selective adenosine A1 antagonists useful in the treatment of neurological disorders such as dementia and depression.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment

View page
US Patent:
20070299101, Dec 27, 2007
Filed:
Oct 31, 2005
Appl. No.:
11/666966
Inventors:
Steven Colletti - Princeton Junction NJ, US
Richard Beresis - Matawan NJ, US
Weichun Chen - Livingston NJ, US
James Tata - Westfield NJ, US
Hong Shen - West Windsor NJ, US
Daria Marley - Hoboken NJ, US
Qiaolin Deng - Edison NJ, US
Jessica Frie - Princeton NJ, US
International Classification:
A61K 31/47
A61K 31/195
A61K 31/403
A61K 31/41
A61P 3/10
C07C 233/64
C07D 215/02
C07D 257/04
C07D 487/00
C07D 513/00
C07D 471/02
C07D 217/00
C07D 209/56
A61P 9/00
A61K 31/425
A61K 31/428
A61K 31/437
US Classification:
514292000, 514307000, 514312000, 514366000, 514381000, 514406000, 514411000, 514563000, 514616000, 546146000, 546153000, 546086000, 548151000, 548250000, 548359100, 548449000, 564155000, 564180000
Abstract:
The present invention relates to niacin receptor agonists of formula: (I); as well as pharmaceutically acceptable salts and solvates. The compounds are useful for treating dyslipidemias, and in particular, reducing serum LDL, VLDL and triglycerides, and raising HDL levels. Pharmaceutical compositions and methods of treatment are also included.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment

View page
US Patent:
20090042926, Feb 12, 2009
Filed:
Dec 20, 2006
Appl. No.:
12/086938
Inventors:
Jason Imbriglio - Piscataway NJ, US
Steven L. Colletti - Princeton Junction NJ, US
James R. Tata - Westfield NJ, US
Richard T. Beresis - Matawan NJ, US
Daria Marley - Raleigh NC, US
Subharekha Raghavan - Teaneck NJ, US
Darby Rye Schmidt - Clark NJ, US
Ashley Rouse Lins - Edison NJ, US
Abigail L. Smenton - Brooklyn NJ, US
Weichun Chen - Livingston NJ, US
Hong Shen - West Windsor NJ, US
Rena Bodner - New York NY, US
International Classification:
A61K 31/4439
C07C 229/34
C07D 277/22
C07D 271/06
C07D 413/04
A61K 31/437
A61P 9/10
A61P 3/10
C07D 471/04
A61K 31/196
A61K 31/426
A61K 31/4245
US Classification:
514293, 562457, 548204, 548131, 5462694, 546 86, 514563, 514365, 514364, 514340
Abstract:
The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment

View page
US Patent:
20090170891, Jul 2, 2009
Filed:
Apr 6, 2007
Appl. No.:
12/226050
Inventors:
Steven L. Colletti - Princeton Junction NJ, US
James R. Tata - Westfield NJ, US
Weichun Chen - Livingston NJ, US
Richard T. Beresis - San Francisco CA, US
Darby Rye Schmidt - Clark NJ, US
Hong Shen - West Windsor NJ, US
Subharekha Raghavan - Teaneck NJ, US
International Classification:
A61K 31/4375
C07D 333/36
A61K 31/381
C07D 413/04
A61K 31/444
C07D 333/38
A61P 3/10
US Classification:
514292, 549 69, 514447, 5462694, 514340, 549 61
Abstract:
The present invention encompasses compounds of Formula I:as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Niacin Receptor Agonists, Compositions Containing Such Compounds And Methods Of Treatment

View page
US Patent:
20100204278, Aug 12, 2010
Filed:
Oct 16, 2007
Appl. No.:
12/445704
Inventors:
Richard T. Beresis - San Francisco CA, US
Steven L. Colletti - Princeton Junction NJ, US
International Classification:
A61K 31/444
C07D 413/14
A61K 31/4439
A61P 3/10
A61P 9/10
US Classification:
514333, 5462694, 514338, 546256
Abstract:
The present invention encompasses compounds of Formula (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

Wikipedia

Triethylsilane

View page

Richard T. Beresis, Jason S. Solomon, Michael G. Yang, Nareshkumar F. Jain, and James S. Panek (1998), "Synthesis of Chiral (E)-Crotylsilanes: [3R- AND ...
Control profile
Richard T Beresis from San Francisco, CA, age ~58 Get Report